Kenya is a country in East Africa with coastline on the Indian Ocean. It encompasses savannah, Lakelands, the dramatic Great Rift Valley, mountain highlands and abundant wildlife such as lions, elephants and rhinos.
Kenyan Pharmaceutical Market at Glance:
- Kenya is currently largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50% of the regions’ market. Out of the region’s estimated of 50 recognized pharmaceutical manufacturers; approximately 30 are based in Kenya.
- Kenya's pharmaceutical industry is on a rebound, riding on the back of increased expenditure in healthcare and general economic growth over the years.
- The rapid growth of the pharmaceutical market in the region has presented the need to increase quantity of production, and also increase the export ratio for quality products. Kenya is currently the largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50 percent of the region’s market.
- The country’s pharmaceutical and consumer health market is estimated to be worth an estimated USD 160 million each year.
- Sales of over-the-counter (OTC) and prescription drugs clocked up sales of 17.7 billion Kenyan shillings (USD 234.6 million) in 2008, up 22.9% from Sh14.4 billion the previous year, according to the Kenya Pharmaceutical and Health Report 2010.
- By 2014, the Kenyan drug market is expected to hit a value of Sh33.5 billion, equating to a compound annual growth rate (CAGR) of 13.53% in local currency terms and 22.8% in US dollar terms.
- The pharmaceutical sector consists of more than 35 licensed units include local manufacturing companies and large Multi National Corporations (MNCs), subsidiaries or joint ventures. Most are located within Nairobi and its environs. These firms collectively employ over 2,000 people, about 65% of who work in direct production
- The industry compounds and packages medicines, repacking formulated drugs and processing bulk drugs into doses using predominantly imported active ingredients and excipients. The bulk of locally manufactured preparations are non-sterile, over-the-counter (OTC) products.
- The number of companies engaged in manufacturing and distribution of pharmaceutical products in Kenya continue to expand, driven by the Government’s efforts to promote local and foreign investment in the sector.
- Kenya enjoys preferential access to the regional market under a number of special access and duty reduction programmes related to the East African Community (EAC) and the Common Market for Eastern and Southern Africa (COMESA) among others.
- The country exports its medicinal and pharmaceutical products to Tanzania, Uganda, DRC, Rwanda, Burundi, the Comoros, Ethiopia and Malawi among other destinations.
- The value of Kenyan medicinal and pharmaceutical products exported increased from KShs 1.6 billion in 1999 to 2.1 billion in 2003.
(Source: Frost & Sullivan & Kenyan Pack Expo)
State of Art pharmaceutical machinery for Kenya:
From above, it is quite pertinent that Kenya is exciting growth story in pharmaceutical arena & N.K Industries, India with its expertise in pharmaceutical machinery since 3 decade has & can become valuable partner for growth story of Kenyan pharmaceutical industries.
N.K Industries can offer various solutions like:
- Complete turkey project line like injectable dry powder line , injectable liquid line ,oral liquid line etc.
- Wide range of pharmaceutical machinery under one roof.
- 24X 7 after sales support.
